The effects of ozone therapy and coenzyme Q10 combination on oxidative stress markers in healthy subjects
- 214 Downloads
Ozone therapy is employed as a therapeutic agent in various diseases. Since ozone itself is a radical, using a small dosage of it is known to create an oxidative preconditioning in the body and trigger a strong antioxidant response against that. Coenzyme Q10, as a strong antioxidant agent, is delivered as a supportive factor in many diseases involving oxidative stress.
The aim of the study was to evaluate the effects of the combination treatment over oxidative stress in healthy individuals.
In the current study, 11 healthy volunteers were administered a combination of ozone therapy and Q10 for 1 month. Blood samples were collected first right after the initial ozone therapy and then 1 month after the ozone therapy + coenzyme Q10 treatment. We measured erythrocyte superoxide dismutase and catalase enzyme activities along with serum malondialdehyde levels.
Compared with the pretreatment values, an increase was determined in the erythrocyte superoxide dismutase and catalase enzyme activities. However, malondialdehyde, an indicator of oxidative membrane damage, showed a reduction after the combination treatment.
The results of this study reveal the beneficial effects of ozone therapy + coenzyme Q10 combination in prevention of oxidative damage.
KeywordsCoenzyme Q10 Malondialdehyde Ozone therapy Oxidative stress Superoxide dismutase
We thank Maya Sante Medical Center (Eskisehir) and its staff for providing samples from healthy subjects subjected to ozone therapy and Co Q10.
Conflict of interest
- 10.Xing HB, Liu X, Zhan B, Zhou J, Zhu H, Chen Z (2008) Similarities between ozone oxidative preconditioning and ischemic preconditioning in renal ischemia/reperfusion injury. Chen Arch Med Res 39:169–178Google Scholar
- 12.Cooke M, Iosia M, Buford T et al (2008) Effects of acute and 14-day coenzyme Q10 supplementation on exercise performance in both trained and untrained individuals. J Int Soc Sports Nutr 4:5–8Google Scholar
- 13.Winterborn CC, Hawkins RE, Brain M et al (1975) The estimation of red cell superoxide dismutase activity. J Lab Clin Med 85:337–341Google Scholar
- 14.Beutler E (1982) Catalase. Manual of biochemical method. Grune and Stratton, New York, pp 105–106Google Scholar
- 16.Devesa E, Menendez S, Rodrõguez MM, Gome ZM, Garcõa J (1993) Ozone therapy in ischemic cerebrovascular disease. In: Proceedings of 11th ozone world congress (USA) Ozonein Medicine M-4–10 to M-4–18Google Scholar
- 17.Romero A, Menendez S, Gomez M, Ley J (1993) Ozone therapy in the advanced stages of arteriosclerosis obliterans. Angiologõa 45:146–148Google Scholar
- 18.Menendez S, Iglesias O, Bidot C, Puga R, Carballo A (1995) Application of ozone therapy in children with humoral immunity deficiency. In: International Ozone Association (ed) Proceedings of 12th ozone world congress, ozone in medicine. Lille, pp 271–274Google Scholar
- 19.Bocci V (1996) Ozone as a bioregulator pharmacology and toxicology of ozone therapy today. J Bil Regulat Homeost Agent 10:31–53Google Scholar
- 28.Tiano L, Belardinelli R, Carnevali P, Principi F, Seddaiu G, Littarru GP (2007) Effect of coenzyme Q10 administration on endothelial function and extracellular superoxide dismutase in patients with ischaemic heart disease: a double-blind, randomized controlled study. Eur Heart J 28:2249–2255PubMedCrossRefGoogle Scholar